Clinical Study of Cizutamig in Systemic Lupus Erythematosus

NCT07215663 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

47

Enrollment

INDUSTRY

Sponsor class

Conditions

Systemic Lupus Erythematosus (SLE)

Interventions

DRUG: Cizutamig

Sponsor

Candid Therapeutics